公開日期 | 標題 | 作者 | 來源出版物 | scopus | WOS | 全文 |
2022 | Ledipasvir/sofosbuvir for HCV genotype 1, 2, 4–6 infection: Real-world evidence from a nationwide registry in Taiwan | Lo C.-C.; Huang C.-F.; Cheng P.-N.; Tseng K.-C.; Chen C.-Y.; Kuo H.-T.; Huang Y.-H.; Tai C.-M.; Peng C.-Y.; Bair M.-J.; Chen C.-H.; Yeh M.-L.; Lin C.-L.; Lin C.-Y.; Lee P.-L.; Chong L.-W.; Hung C.-H.; Chang T.S.; Huang J.-F.; Yang C.-C.; Hu J.-T.; Lin C.-W.; Chen C.-T.; Wang C.-C.; Su W.-W.; Hsieh T.-Y.; Lin C.-L.; Tsai W.-L.; Lee T.-H.; Chen G.-Y.; Wang S.-J.; Chang C.-C.; Mo L.-R.; Yang S.-S.; Wu W.-C.; Huang C.-S.; Hsiung C.-K.; Kao C.-N.; Tsai P.-C.; CHEN-HUA LIU ; Lee M.-H.; CHUN-JEN LIU ; Dai C.-Y.; Chuang W.-L.; Lin H.-C.; JIA-HORNG KAO ; Yu M.-L.; TACR investigators | Journal of the Formosan Medical Association | 3 | 0 | |
2010 | Letter to the editor | Wang C.-C.; JIA-HORNG KAO | New England Journal of Medicine | 2 | | |
2017 | Letter: the influence of direct acting agents for hepatitis C, on hepatitis B reactivation | Wang C.-C.; JIA-HORNG KAO | Alimentary Pharmacology and Therapeutics | 0 | 0 | |
2021 | Long-term outcome of liver complications in patients with chronic HBV/HCV co-infection after antiviral therapy: a real-world nationwide study on Taiwanese Chronic Hepatitis C Cohort (T-COACH) | Yeh M.-L.; Hung C.-H.; Tseng K.-C.; Lai H.-C.; Chen C.-Y.; Kuo H.-T.; Wang J.-H.; Chen J.-J.; Lee P.-L.; Chien R.-N.; Yang C.-C.; Lo G.-H.; Tai C.-M.; Lin C.-W.; JIA-HORNG KAO ; CHEN-HUA LIU ; Yan S.-L.; Bair M.-J.; Lin C.-Y.; Su W.-W.; Chu C.-H.; Chen C.-J.; Tung S.-Y.; Lo C.-C.; Cheng P.-N.; Chiu Y.-C.; Wang C.-C.; Cheng J.-S.; Tsai W.-L.; Lin H.-C.; Huang Y.-H.; Huang C.-F.; Huang J.-F.; Dai C.-Y.; Chuang W.-L.; Tsai P.-C.; Peng C.-Y.; CHUN-JEN LIU ; Yu M.-L. | Hepatology International | 4 | 5 | |
2021 | Long-term risk of end-stage renal diseases with maintenance dialysis among chronic hepatitis C patients after antiviral therapy in Taiwan | Hsieh M.-H.; Bair M.-J.; Tsai P.-C.; Tseng K.-C.; Lo C.-C.; Chen C.-Y.; Kuo H.-T.; Hung C.-H.; Lai H.-C.; Peng C.-Y.; Wang J.-H.; Chen J.-J.; Lee P.-L.; Chien R.-N.; Yang C.-C.; Lo G.-H.; JIA-HORNG KAO ; CHUN-JEN LIU ; CHEN-HUA LIU ; Yan S.-L.; Lin C.-Y.; Su W.-W.; Chu C.-H.; Chen C.-J.; Tung S.-Y.; Tai C.-M.; Lin C.-W.; Cheng P.-N.; Chiu Y.-C.; Wang C.-C.; Cheng J.-S.; Tsai W.-L.; Lin H.-C.; Huang Y.-H.; Yeh M.-L.; Huang C.-F.; Huang J.-F.; Dai C.-Y.; Yu M.-L.; Chuang W.-L.; T-COACH investigators | Journal of Gastroenterology and Hepatology (Australia) | 2 | 3 | |
2012 | Loss of the candidate tumor suppressor BTG3 triggers acute cellular senescence via the ERK-JMJD3-p16 INK4a signaling axis | Lin T.-Y.; Cheng Y.-C.; Yang H.-C.; WEI-CHOU LIN ; Wang C.-C.; Lai P.-L.; Shieh S.-Y. | Oncogene | 42 | 41 | |
2018 | Management consensus guideline for hepatocellular carcinoma: 2016 updated by the Taiwan Liver Cancer Association and the Gastroenterological Society of Taiwan | Wang, CK; MING-CHIH HO ; Su C.-W.; Wang T.-E.; Dai C.-Y.; CHIEN-HUNG CHEN ; Chen R.-C.; Yang S.-S.; Hung C.-F.; Huang S.-F.; Liao L.-Y.; Huo T.-I.; Wu C.-C.; PO-HUANG LEE ; Ting C.-T.; Lee W.-C.; Chau G.-Y.; Wang C.-C.; Lee K.-T.; Huang Y.-H.; Lin S.-M.; GUAN-TARN HUANG ; Chen K.-Y.; Lin X.-Z.; Hwang J.-I.; Chiou Y.-Y.; Wang C.-K.; Hu J.-T.; Chen S.-C.; PO-CHIN LIANG ; Lee R.-C.; Wu D.-K.; Lin C.-Y.; Lin C.-C.; ANN-LII CHENG ; CHIUN HSU ; Chao Y.; Chen L.-T.; Wang P.-M.; Wang P.-M.; Hong J.-H.; Hsu H.-C.; Chen S.-W.; Leung S.W.; CHIA-HSIEN CHENG ; Wu J.-C.; Wu C.-Y.; Hsu Y.-C.; Hsu C.-W.; YEN-HSUAN NI ; Lin C.-L.; Local ablation group, Surveillance group, Diagnosis group, Staging group, Surgery group, TACE/TARE/HAI group, Target therapy/systemic therapy group, Radiotherapy group, Prevention group, Drafting group; Surveillance group; Diagnosis group; Staging group; Surgery group; TACE/TARE/HAI group; Target therapy/systemic therapy group; Radiotherapy group; Prevention group; Drafting group | Journal of the Formosan Medical Association = Taiwan yi zhi | 89 | 87 | |
2016 | Management of venous thromboembolisms: Part i. the consensus for deep vein thrombosis | Wang K.-L.; Chu P.-H.; Lee C.-H.; Pai P.-Y.; Lin P.-Y.; Shyu K.-G.; WEI-TIEN CHANG ; Chiu K.-M.; Huang C.-L.; Lee C.-Y.; YEN-HUNG LIN ; Wang C.-C.; Yen H.-W.; Yin W.-H.; Yeh H.-I.; Chiang C.-E.; Lin S.-J.; Yeh S.-J. | Acta Cardiologica Sinica | 34 | 33 | |
2001 | Matrix metalloproteinase-1 and tissue inhibitor of metalloproteinase-1 gene expressions and their differential regulation by proinflammatory cytokines and prostaglandin in nasal polyp fibroblasts | Hong C.-Y.; Hsiao T.-Y.; Liu C.-M.; CHIA-TUNG SHUN ; Wang C.-C.; Wang J.-S.; SZE-KWAN LIN | Annals of Otology, Rhinology and Laryngology | 23 | 23 | |
2013 | Matrix variate logistic regression model with application to EEG data | Hung Hung ; Wang C.-C. | Biostatistics | 50 | 48 | |
2006 | A mechanical-electrokinetic battery using a nano-porous membrane | MING-CHANG LU ; Lu M.-C.; Satyanarayana S.; Karnik R.; Majumdar A.; Wang C.-C. | Journal of Micromechanics and Microengineering | 52 | 48 | |
2004 | MEK/ERK and Signal Transducer and Activator of Transcription Signaling Pathways Modulate Oncostatin M-Stimulated CCL2 Expression in Human Osteoblasts Through a Common Transcription Factor | SZE-KWAN LIN ; SANG-HENG KOK ; Tzu-Chin Yeh F.; YEN-PING KUO ; Lin C.-C.; Wang C.-C.; Goldring S.R.; Hong C.-Y. | Arthritis and Rheumatism | 44 | 40 | |
1991 | Menadione-induced DNA damage in a human tumor cell line | Ngo E.O.; Sun T.-P.; Chang J.-Y.; Wang C.-C.; Chi K.-H.; ANN-LII CHENG ; Nutter L.M. | Biochemical Pharmacology | 69 | 75 | |
2021 | The metabolic profiles and body composition of lean metabolic associated fatty liver disease | Cheng Y.-M.; JIA-HORNG KAO ; Wang C.-C. | Hepatology International | 19 | 17 | |
2023 | Metastatic tumor antigen 1 contributes to hepatocarcinogenesis posttranscriptionally through RNA-binding function | Li Y.-T.; CHUN-JEN LIU ; JIA-HORNG KAO ; Lin L.-F.; Tu H.-C.; Wang C.-C.; Huang P.-H.; Cheng H.-R.; PEI-JER CHEN ; DING-SHINN CHEN ; Wu H.-L. | Hepatology | 1 | 1 | |
2010 | Metformin improves sustained virologic response in difficult-to-cure hepatitis c: More questions than answers | Wang C.-C.; JIA-HORNG KAO | Hepatology | 3 | 3 | |
2018 | Micrometer-Sized Nanoporous Sb/C Anode with High Volumetric Capacity and Fast Charging Performance for Sodium-Ion Batteries | Selvaraj B.; Huang S.-S.; Wu C.-E.; Lin Y.-H.; Wang C.-C.; Song Y.-F.; Lu M.-L.; Sheu H.-S.; Wu N.-L. | ACS Applied Energy Materials | 20 | 19 | |
2019 | Multi-scale mapping for collagen-regulated mineralization in bone remodeling of additive manufacturing porous implants | Tsai P.-I.; Lam T.-N.; Wu M.-H.; Tseng K.-Y.; Chang Y.-W.; JUI-SHENG SUN ; Li Y.-Y.; Lee M.-H.; Chen S.-Y.; Chang C.-K.; Su C.-J.; Lin C.-H.; Chiang C.-Y.; Ku C.-S.; Tsou N.-T.; Shih S.-J.; Wang C.-C.; Huang E.-W. | Materials Chemistry and Physics | 17 | 15 | |
2019 | Multi-scale microstructure investigation for a pm2.5 air-filter efficiency study of non-woven polypropylene | Lam T.-N.; Wu C.-H.; SHENG-HSIU HUANG ; Ko W.-C.; Huang Y.-L.; Ma C.-Y.; Wang C.-C.; Huang E.-W. | Quantum Beam Science | 15 | 16 | |
2006 | Multifunctional transcription factor YY1: A therapeutic target in human cancer? | Wang C.-C.; Chen J.J.W.; PAN-CHYR YANG | Expert Opinion on Therapeutic Targets | 45 | 39 | |